CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-6 AfternoonBeacon Equity ResearchTheir market cap is 13.73B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-thr…
Isotechnika makes executive changes – Globe and Mail
Globe and MailIsotechnika makes executive changesGlobe and Mail“This change is designed to allow Dr. Foster to continue to focus firmly on Phase 3 development activities of the company's leading product candidate, voclosporin, for the prevention …
Blood Donation Campaign held at Welisara Naval Base – Sri Lanka Navy
Sri Lanka NavyBlood Donation Campaign held at Welisara Naval BaseSri Lanka NavyA blood donation campaign was held at the Naval Base in Welisara on 06th January 2012. A large number of naval personnel from SLNS Gemunu, Thakshila and Mahasen participated…
Nick Cannon's 'Mild' Kidney Failure Explained – Parade Magazine
Parade MagazineNick Cannon's 'Mild' Kidney Failure ExplainedParade MagazineAcute kidney injury occurs when the kidneys stop functioning properly, thereby allowing fluids, waste and electrolytes to store up in the body. It can be diagnosed b…
Host cell species-specific effect of cyclosporine A on simian immunodeficiency … – 7thSpace Interactive (press release)
Host cell species-specific effect of cyclosporine A on simian immunodeficiency …7thSpace Interactive (press release)In the present study, we examined the effect of cyclosporine A (CsA), a PPIase inhibitor, on SIV replication. Results: SIV replication…
EyeGate Pharma begins phase 3 study on potential treatment for anterior uveitis – OSN SuperSite
EyeGate Pharma begins phase 3 study on potential treatment for anterior uveitisOSN SuperSiteEGP-437 administered with the EyeGate II Drug Delivery System will have its effectiveness measured against topically applied prednisolone acetate eye drops. &qu…
Isotechnika Announces Changes to Senior Management and Board of Directors – MarketWatch (press release)
Isotechnika Announces Changes to Senior Management and Board of DirectorsMarketWatch (press release)This change is designed to allow Dr. Foster to continue to focus firmly on Phase 3 development activities of the Company's leading product candidate…
Drug that could slow spread of breast cancer available in clinical trial at … – KyForward.com
KyForward.comDrug that could slow spread of breast cancer available in clinical trial at …KyForward.comThe novel agent, everolimus/RAD001 (BOLERO-2), was given in conjunction with a hormone therapy treatment called exemestane that deprives tumors of …
TrovaGene to Buy MultiGen's CLIA Lab to Bolster Infectious Disease Testing – Genetic Engineering News
TrovaGene to Buy MultiGen's CLIA Lab to Bolster Infectious Disease TestingGenetic Engineering NewsThe firm says it has achieved proof-of-principle for candidate markers in infectious disease testing, cancer detection and monitoring, organ transplan…
Things to Know: Upcoming Blood Donation Drive – Patch.com
Things to Know: Upcoming Blood Donation DrivePatch.comBlood Centers of the Pacific and San Bruno's Lunardi's Market join John Muir Elementary School in sponsoring its 2nd annual blood donation drive. Here are some important things happening aro…